Figure 2 from Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer

Read full text
Authors: Esther Sanfeliu, Anabel Martínez-Romero, Mercedes Marín‐Aguilera, Sandra Cobo, Blanca González‐Farré, Eva Hernández‐Illán, Pedro Jares, Joan Anton Puig‐Butille, Montserrat Muñoz-Mateu, Raquel Gómez-Bravo, Marta Tapia, Cristina Tebar
+17 more Cristina Saura, Santiago Escrivá-de-Romaní, Jesús Soberino, Javier Cortés, Serafin M. Morales, Kepa Amillano, Laia Paré, Patricia Villagrasa, Wesley Buckingham, Francisco Pardo, Joel S. Parker, Fara Brasó‐Maristany, Eva Ciruelos, Rodrigo Sánchez-Bayona, Olga Martínez‐Sáez, Juan Miguel Cejalvo, Aleix Prat
Cited by: 0

Abstract

Associations between HER2DX pCR score and standard pathologic features. Distribution of HER2DX pCR score groups (low, medium, and high; A); HER2DX pCR score by tumor grade (B), HR status (C), HER2 IHC status (D), TLS status (E), and spatial immune distribution (F). All scores are shown on a continuous scale from 1 to 99. Boxplots show IQR with medians indicated and display score distributions across groups. Statistical comparisons were performed using appropriate parametric tests.

Fields of Study & Subjects

HER2/EGFR in Cancer Research Breast Cancer Treatment Studies Breast Lesions and Carcinomas

Publication details

Publication date
4 February 2026